Episode 206 - Valerie Vanhooren - CEO & Co-Founder Ona Therapeutics

In this episode of The BioHub by Avetix, I'm joined by Valerie Vanhooren, CEO and Co-Founder of Ona Therapeutics.Recorded shortly after Ona Therapeutics announced its $85 million Series B, Valerie shares the journey behind building the company, the challenges of fundraising in today's biotech market, and the opportunity to develop next-generation precision oncology therapies that improve outcomes for patients with cancer.We also discuss the evolution of antibody-drug conjugates (ADCs), what it takes to build a biotech from the ground up, the importance of company culture, and Valerie's vision for the future of precision oncology.